It supports energy production, helps maintain healthy nerve cells, and is essential for making red blood cells
Patients who have had their band removed or adjusted, or who have experienced significant weight regain, may have altered nutritional needs and should seek reassessment from their bariatric team
BPC-157 & TB-500 Blend (Wolverine Peptide Blend) is a research formulation combining two bioactive peptides frequently investigated in studies of tissue signaling, cellular migration, and regenerative biology
According to USDA Agricultural Research Service data based on NHANES, approximately 6% of adults aged 60 and older in the United States are vitamin B12 deficient, defined as plasma B12 below 148 pmol/L (2009)
Reviewed by: FormBlends Medical Team | Last updated: May 29, 2026 | Sources: USP general chapters, FDA compounding guidance, peer-reviewed GLP-1/GIP pharmacology literature, manufacturer prescribing information
Triple-hormone-receptor agonist Retatrutide for obesity: Phase 2 trial (48-week study, up to 24% weight loss) American Diabetes Association (2023) ADA Press Release: Novel agent Retatrutide results in substantial weight reduction (83rd Scientific Sessions, Phase 2 data) ADA Meeting News (2023) Phase 2 trial results: benefits of Retatrutide in obesity, type 2 diabetes, NASH (83rd ADA Scientific Sessions coverage) ClinicalTrials.gov Study of Retatrutide (LY3437943) in adults with obesity (NCT04881760